S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
Denmark says Nord Stream 1 pipelines stop leaking
Brazil holds historic election with Lula against Bolsonaro
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
US shift away from coal hits tribal community in New Mexico
Allies aim for risky Russian oil price cap as winter nears
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
Denmark says Nord Stream 1 pipelines stop leaking
Brazil holds historic election with Lula against Bolsonaro
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
US shift away from coal hits tribal community in New Mexico
Allies aim for risky Russian oil price cap as winter nears
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
Denmark says Nord Stream 1 pipelines stop leaking
Brazil holds historic election with Lula against Bolsonaro
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
US shift away from coal hits tribal community in New Mexico
Allies aim for risky Russian oil price cap as winter nears
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
EU chief: New Greece-Bulgaria gas pipeline 'means freedom'
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
Denmark says Nord Stream 1 pipelines stop leaking
Brazil holds historic election with Lula against Bolsonaro
Market Wizard Reveals: The One Ticker Retirement Plan (Ad)pixel
US shift away from coal hits tribal community in New Mexico
Allies aim for risky Russian oil price cap as winter nears
OTCMKTS:DSNKY

Daiichi Sankyo - DSNKY Stock Forecast, Price & News

$28.06
+0.21 (+0.75%)
(As of 09/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$27.50
$28.45
50-Day Range
$24.35
$31.83
52-Week Range
$19.39
$32.35
Volume
117,796 shs
Average Volume
121,249 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
DSNKY stock logo

About Daiichi Sankyo (OTCMKTS:DSNKY) Stock

Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells pharmaceutical products worldwide. The company offers trastuzumab deruxtecan, an anti-cancer agent and anti-HER2 antibody drug conjugate; mirogabalin for pain treatment; teneligliptin/canagliflozin for type 2 diabetes mellitus treatment; lacosamide anti-epileptic agent; prasugrel, an antiplatelet agent; denosumab for osteoporosis and bone disorders; teneligliptin for type 2 diabetes mellitus treatment; edoxaban, an anticoagulant; esomeprazole for ulcer treatment; memantine for treating Alzheimer's disease; and laninamivir for anti-influenza treatment. It also provides olmesartan, an antihypertensive agent; levofloxacin, an antibacterial agent; pravastatin for hypercholesterolemia treatment; and loxoprofen, an anti-inflammatory analgesic. In addition, the company offers colesevelam for treating hypercholesterolemia and type 2 diabetes mellitus treatment; and ferric carboxymaltose and iron sucrose injections for treating anemia. Further, it provides Lulu, a combination cold remedy; Loxonin S, an antipyretic analgesic /anti-inflammatory analgesic; Transino for melasma improvement and treating against spots and freckles; Minon, a skincare product; and Breath Labo and Clean Dental oral care products, as well as Silodosin for dysuria; Gefitinib for malignant tumours; Bicalutamide for prostate cancer; and Tamoxifen, an anti-breast cancer agent. Additionally, the company offers adsorbed cell culture-derived influenza, influenza HA, measles rubella combined, and mumps vaccines. It also provides pharmaceuticals and drugs for animals, cosmetics, medical equipment, food products, drinking water, active pharmaceutical ingredients, and intermediates. It has collaboration with Guardant Health to develop Guardant360 CDx as a companion diagnostic for Enhertu in advanced metastatic non-small cell lung cancer. The company was founded in 1899 and is headquartered in Tokyo, Japan.

Receive DSNKY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Daiichi Sankyo and its competitors with MarketBeat's FREE daily newsletter.

DSNKY Stock News Headlines

DSNKY Daiichi Sankyo Company, Limited
Daiichi Sankyo Company, Limited (DSNKY)
Why MacroGenics Stock Sank Today
See More Headlines
Receive DSNKY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Daiichi Sankyo and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Pharmaceuticals: Other
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:DSNKY
CIK
N/A
Fax
N/A
Employees
16,033
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Sunao Manabe D.V.M. (Age 68)
    Ph.D., Pres, Group CEO & Representative Director
    Comp: $954.07k
  • Mr. Hiroyuki Okuzawa (Age 60)
    Sr. Exec. Officer, Global Head of Corp. Planning & Management Div., CFO and Director
  • Mr. Masahiko Ohtsuki (Age 63)
    Sr. Exec. Officer, Global Head of Digital Transformation Management Div., CIO & Director
  • Naoto Tsukaguchi
    Gen. Counsel, Corp. Officer, VP of Legal Affairs Dept. & Corp. Affairs Division
  • Mr. Junichi Onuma
    VP of Corp. Communications Department
  • Ms. Marielle Cohard-Radice M.D.
    Global Head of Devel.
  • Yoshinori Kaneshima
    Corp. Officer and Head of Marketing Div. & Japan Bus. Unit
  • Akio Sakurai
    Corp. Officer and Head of Sales Div. & Japan Bus. Unit
  • Takashi Matsumoto
    Corp. Officer & Global Head of HR
  • Mr. Hideyuki Haruyama Ph.D.
    Corp. Adviser













DSNKY Stock - Frequently Asked Questions

Should I buy or sell Daiichi Sankyo stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Daiichi Sankyo in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" DSNKY shares.
View DSNKY analyst ratings
or view top-rated stocks.

How have DSNKY shares performed in 2022?

Daiichi Sankyo's stock was trading at $25.51 at the start of the year. Since then, DSNKY shares have increased by 10.0% and is now trading at $28.06.
View the best growth stocks for 2022 here
.

Are investors shorting Daiichi Sankyo?

Daiichi Sankyo saw a decline in short interest during the month of September. As of September 15th, there was short interest totaling 112,300 shares, a decline of 33.8% from the August 31st total of 169,600 shares. Based on an average daily volume of 143,500 shares, the short-interest ratio is currently 0.8 days.
View Daiichi Sankyo's Short Interest
.

What guidance has Daiichi Sankyo issued on next quarter's earnings?

Daiichi Sankyo updated its FY 2023 earnings guidance on Friday, August, 5th. The company provided earnings per share guidance of $0.33-$0.33 for the period. The company issued revenue guidance of $8.88 billion-$8.88 billion.

What is Daiichi Sankyo's stock symbol?

Daiichi Sankyo trades on the OTCMKTS under the ticker symbol "DSNKY."

How do I buy shares of Daiichi Sankyo?

Shares of DSNKY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Daiichi Sankyo's stock price today?

One share of DSNKY stock can currently be purchased for approximately $28.06.

How many employees does Daiichi Sankyo have?

The company employs 16,033 workers across the globe.

How can I contact Daiichi Sankyo?

Daiichi Sankyo's mailing address is Daiichi Sankyo Bldg. A/B Kan, Chuo Ku, Tokyo To 103-8426. The official website for the company is www.daiichisankyo.com. The company can be reached via phone at (136) 225-1111.

This page (OTCMKTS:DSNKY) was last updated on 10/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.